PACIFIC BIOSCIENCES OF CALIF (PACB) Stock Analyst Earnings Estimates
NASDAQ:PACB - Nasdaq - US69404D1081 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 130.5M 65.40% | 128.3M -1.69% | 200.521M 56.29% | 158.57M -20.92% | 190.11M 19.89% | 250.26M 31.64% | 326.18M 30.34% | 375.39M 15.09% | 500.11M 33.22% | 580.33M 16.04% | 691.05M 19.08% | 773.87M 11.98% | |
| EBITDA YoY % growth | -171.72M -75.28% | -293.11M -70.69% | -302.265M -3.12% | -280.476M 7.21% | -175.749M 37.34% | -138.948M 20.94% | -99.45M 28.43% | -37.74M 62.05% | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -179.3M -71.74% | -303.5M -69.27% | -321.989M -6.09% | -314.571M 2.30% | -203.128M 35.43% | -173.473M 14.60% | -136.048M 21.57% | -84.66M 37.77% | 49.266M 158.19% | 91.137M 84.99% | 90.474M -0.73% | 145.45M 60.76% | |
| Operating Margin | -137.39% | -236.55% | -160.58% | -198.38% | -106.85% | -69.32% | -41.71% | -22.55% | 9.85% | 15.70% | 13.09% | 18.80% | |
| EPS YoY % growth | -1.20 -823.08% | -1.40 -16.67% | -1.21 13.57% | -1.39 -14.74% | -0.69 50.21% | -0.57 18.23% | -0.43 23.76% | -0.33 23.48% | -0.04 87.63% | N/A | N/A | N/A |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.21 33.02% | -0.18 36.98% | -0.18 72.24% | -0.17 24.27% | -0.17 16.04% | -0.18 -0.46% | -0.17 2.39% | -0.14 14.28% | -0.16 10.29% |
| Revenue Q2Q % growth | 41.025M -29.70% | 42.48M 9.46% | 45.534M 26.44% | 49.699M 24.35% | 54.406M 32.62% | 59.058M 39.03% | 57.497M 26.27% | 63.73M 28.23% | 68.009M 25.00% |
| EBITDA Q2Q % growth | -52.624M 18.19% | -40.512M 43.16% | -44.609M 27.11% | -41.286M -26.69% | -41.13M 21.84% | -51.122M -26.19% | -48.338M -8.36% | -46.706M -13.13% | -44.207M -7.48% |
| EBIT Q2Q % growth | -61.535M 26.79% | -52.499M 35.47% | -52.257M 36.00% | -48.091M 24.95% | -52.043M 15.43% | -53.168M -1.27% | -52.239M 0.03% | -41.239M 14.25% | -50.776M 2.44% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.22 15.38% | -0.23 | 0.01 | 3.93% |
| Q2 2024 Q2Q % growth | -0.64 -128.57% | -0.24 | -0.40 | -169.73% |
| Q1 2024 Q2Q % growth | -0.29 19.44% | -0.28 | -0.01 | -3.24% |
| Q4 2023 Q2Q % growth | -0.31 16.22% | -0.29 | -0.02 | -6.56% |
| Q3 2023 Q2Q % growth | -0.26 23.53% | -0.33 | 0.07 | 22.31% |
| Q2 2023 Q2Q % growth | -0.28 12.50% | -0.33 | 0.05 | 14.39% |
| Q1 2023 Q2Q % growth | -0.36 2.70% | -0.34 | -0.02 | -6.15% |
| Q4 2022 Q2Q % growth | -0.37 -19.35% | -0.37 | 0.00 | -0.41% |
| Q3 2022 Q2Q % growth | -0.34 -47.83% | -0.34 | 0.00 | -0.50% |
| Q2 2022 Q2Q % growth | -0.32 -52.38% | -0.33 | 0.01 | 2.97% |
| Q1 2022 Q2Q % growth | -0.37 17.78% | -0.31 | -0.06 | -17.65% |
| Q4 2021 Q2Q % growth | -0.31 -183.78% | -0.29 | -0.02 | -7.27% |
| Q3 2021 Q2Q % growth | -0.23 -64.29% | -0.22 | -0.01 | -3.67% |
| Q2 2021 Q2Q % growth | -0.21 -40.00% | -0.21 | 0.00 | 0.06% |
| Q1 2021 Q2Q % growth | -0.45 -114.29% | -0.47 | 0.02 | 3.67% |
| Q4 2020 Q2Q % growth | 0.37 | 0.32 | 0.05 | 14.07% |
| Q3 2020 Q2Q % growth | -0.14 26.32% | -0.14 | 0.00 | -2.43% |
| Q2 2020 Q2Q % growth | -0.15 6.25% | -0.18 | 0.03 | 18.30% |
| Q1 2020 Q2Q % growth | -0.21 -5.00% | -0.16 | -0.05 | -30.72% |
| Q4 2019 Q2Q % growth | 0.00 | -0.17 | 0.17 | 100.00% |
| Q3 2019 Q2Q % growth | -0.19 | -0.15 | -0.04 | -24.18% |
| Q2 2019 Q2Q % growth | -0.16 | -0.16 | 0.00 | 1.96% |
| Q1 2019 Q2Q % growth | -0.20 | -0.16 | -0.04 | -29.00% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 39.967M -28.23% | 42.794M | -2.827M | -6.61% |
| Q2 2024 Q2Q % growth | 36.013M -24.30% | 41.695M | -5.682M | -13.63% |
| Q1 2024 Q2Q % growth | 38.81M -0.23% | 43.821M | -5.011M | -11.44% |
| Q4 2023 Q2Q % growth | 58.357M 113.37% | 58.635M | -278K | -0.47% |
| Q3 2023 Q2Q % growth | 55.691M 72.36% | 49.736M | 5.955M | 11.97% |
| Q2 2023 Q2Q % growth | 47.573M 34.12% | 41.104M | 6.469M | 15.74% |
| Q1 2023 Q2Q % growth | 38.9M 17.27% | 35.071M | 3.829M | 10.92% |
| Q4 2022 Q2Q % growth | 27.35M -24.07% | 26.762M | 588K | 2.20% |
| Q3 2022 Q2Q % growth | 32.31M -7.39% | 36.108M | -3.798M | -10.52% |
| Q2 2022 Q2Q % growth | 35.47M 15.88% | 35.863M | -393K | -1.10% |
| Q1 2022 Q2Q % growth | 33.17M 14.38% | 33.476M | -306K | -0.91% |
| Q4 2021 Q2Q % growth | 36.02M 32.72% | 36.842M | -822K | -2.23% |
| Q3 2021 Q2Q % growth | 34.89M 82.86% | 33.898M | 992K | 2.93% |
| Q2 2021 Q2Q % growth | 30.61M 79.22% | 30.589M | 21K | 0.07% |
| Q1 2021 Q2Q % growth | 29M 85.90% | 26.093M | 2.907M | 11.14% |
| Q4 2020 Q2Q % growth | 27.14M -2.83% | 25.92M | 1.22M | 4.71% |
| Q3 2020 Q2Q % growth | 19.08M -12.96% | 20.758M | -1.678M | -8.08% |
| Q2 2020 Q2Q % growth | 17.08M -30.63% | 13.997M | 3.083M | 22.03% |
| Q1 2020 Q2Q % growth | 15.6M -5.05% | 20.47M | -4.87M | -23.79% |
| Q4 2019 Q2Q % growth | 27.93M | 26.032M | 1.898M | 7.29% |
| Q3 2019 Q2Q % growth | 21.92M | 27.576M | -5.656M | -20.51% |
| Q2 2019 Q2Q % growth | 24.62M | 21.228M | 3.392M | 15.98% |
| Q1 2019 Q2Q % growth | 16.43M | 22.076M | -5.646M | -25.58% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -0.24% | -9% | -5.11% | -6.72% |
| Revenue | -0.69% | -23.72% | -0.06% | -6.64% |